Since the first human respiratory syncytial virus (HRSV) genotype classification in 1998,
inconsistent conclusions have been drawn regarding the criteria that define HRSV genotypes …

The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …

Introduction: COVID-19 Ag Respi-Strip, an immunochromatographic (ICT) assay for the rapid
detection of SARS-CoV-2 antigen on nasopharyngeal specimen, has been developed to …

Treatment with pan-genotypic direct-acting antivirals, targeting different viral proteins, is the
best option for clearing hepatitis C virus (HCV) infection in chronically infected patients. …

COVID-19 vaccination has resulted in excellent protection against fatal disease, including in
the elderly. However, risk factors for post-vaccination fatal COVID-19 are largely unknown. …

The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …

The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 . It has in the meantime spread to many countries and is expected to rapidly …

The emergence of Omicron sublineages impacts the therapeutic efficacy of anti-severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs). Here, …

Background The Invasive Respiratory Infection Surveillance (IRIS) Consortium was
established to assess the impact of the COVID-19 pandemic on invasive diseases caused by …

This retrospective multi-center matched cohort study assessed the risk for severe COVID-19
(combination of severity indicators), intensive care unit (ICU) admission, and in-hospital …